{"id":"https://openalex.org/W2107583569","doi":"https://doi.org/10.1186/ar4347","title":"A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis","display_name":"A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis","publication_year":2013,"publication_date":"2013-10-25","ids":{"openalex":"https://openalex.org/W2107583569","doi":"https://doi.org/10.1186/ar4347","mag":"2107583569","pmid":"https://pubmed.ncbi.nlm.nih.gov/24286136","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3979125"},"language":"en","primary_location":{"id":"doi:10.1186/ar4347","doi":"https://doi.org/10.1186/ar4347","is_oa":true,"landing_page_url":"https://doi.org/10.1186/ar4347","pdf_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/ar4347","source":{"id":"https://openalex.org/S149170128","display_name":"Arthritis Research & Therapy","issn_l":"1478-6354","issn":["1478-6354","1478-6362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Research & Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/ar4347","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"David A Martin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David A Martin","raw_affiliation_strings":["Amgen Inc, 1201 Amgen Court West, Seattle, WA, 98119, USA","Amgen Inc., Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, 1201 Amgen Court West, Seattle, WA, 98119, USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Amgen Inc., Seattle, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074207906","display_name":"Melvin A. Churchill","orcid":"https://orcid.org/0000-0001-8347-185X","observed_orcids":["https://orcid.org/0000-0001-8347-185X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melvin Churchill","raw_affiliation_strings":["Arthritis Center of Nebraska, 3901 Pine Lake Road, Lincoln, NE 68516, USA","Arthritis Center of Nebraska, Lincoln, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arthritis Center of Nebraska, 3901 Pine Lake Road, Lincoln, NE 68516, USA","institution_ids":[]},{"raw_affiliation_string":"Arthritis Center of Nebraska, Lincoln, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080999925","display_name":"Luis Felipe Flores-Su\u00e1rez","orcid":"https://orcid.org/0000-0002-0172-8023","observed_orcids":["https://orcid.org/0000-0002-0172-8023","https://orcid.org/0000-0002-1920-448X"]},"institutions":[{"id":"https://openalex.org/I4210102695","display_name":"Instituto Nacional de Enfermedades Respiratorias","ror":"https://ror.org/017fh2655","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210102695"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Luis Felipe Flores-Suarez","raw_affiliation_strings":["Primary Systemic Vasculitis Clinic, National Institute of Respiratory Diseases, M\u00e9xico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Primary Systemic Vasculitis Clinic, National Institute of Respiratory Diseases, M\u00e9xico City, Mexico","institution_ids":["https://openalex.org/I4210102695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013851404","display_name":"Mario Humberto Cardiel","orcid":"https://orcid.org/0000-0002-2731-9180","observed_orcids":["https://orcid.org/0000-0002-2731-9180"]},"institutions":[{"id":"https://openalex.org/I4210102553","display_name":"Universidad de Morelia","ror":"https://ror.org/00tnb2p82","country_code":"MX","type":"education","lineage":["https://openalex.org/I4210102553"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Mario H Cardiel","raw_affiliation_strings":["Clinical Research Center of Morelia, Morelia, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Center of Morelia, Morelia, Mexico","institution_ids":["https://openalex.org/I4210102553"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071430304","display_name":"Daniel J. Wallace","orcid":"https://orcid.org/0000-0002-2502-1372","observed_orcids":["https://orcid.org/0000-0002-2502-1372"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Wallace","raw_affiliation_strings":["Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA","Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1282927834"]},{"raw_affiliation_string":"Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, USA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035688309","display_name":"Richard W. Martin","orcid":"https://orcid.org/0000-0002-0411-7519","observed_orcids":["https://orcid.org/0000-0002-0411-7519"]},"institutions":[{"id":"https://openalex.org/I87216513","display_name":"Michigan State University","ror":"https://ror.org/05hs6h993","country_code":"US","type":"education","lineage":["https://openalex.org/I87216513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Martin","raw_affiliation_strings":["Division of Rheumatology, College of Medicine, Michigan State University, 775 Ball Avenue NE, Grand Rapids, MI, 49503, USA","Division of Rheumatology, College of Medicine, Michigan State University, Grand Rapids, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Rheumatology, College of Medicine, Michigan State University, 775 Ball Avenue NE, Grand Rapids, MI, 49503, USA","institution_ids":["https://openalex.org/I87216513"]},{"raw_affiliation_string":"Division of Rheumatology, College of Medicine, Michigan State University, Grand Rapids, USA","institution_ids":["https://openalex.org/I87216513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108230332","display_name":"Kristine Phillips","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristine Phillips","raw_affiliation_strings":["Scleroderma Program, Division of Rheumatology, School of Medicine, University of Michigan, 7C27 NIB, 300 N Ingalls Street, Ann Arbor, MI, 48109, USA","Scleroderma Program, Division of Rheumatology, School of Medicine, University of Michigan, Ann Arbor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scleroderma Program, Division of Rheumatology, School of Medicine, University of Michigan, 7C27 NIB, 300 N Ingalls Street, Ann Arbor, MI, 48109, USA","institution_ids":["https://openalex.org/I27837315"]},{"raw_affiliation_string":"Scleroderma Program, Division of Rheumatology, School of Medicine, University of Michigan, Ann Arbor, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023834873","display_name":"Jeffrey Kaine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey L Kaine","raw_affiliation_strings":["Sarasota Arthritis Center, 3500 S Tamiami Trail, Sarasota, FL, 34239, USA","Sarasota Arthritis Center, Sarasota, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarasota Arthritis Center, 3500 S Tamiami Trail, Sarasota, FL, 34239, USA","institution_ids":[]},{"raw_affiliation_string":"Sarasota Arthritis Center, Sarasota, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112080484","display_name":"Hua Dong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hua Dong","raw_affiliation_strings":["Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, 91320, USA","Amgen Inc, Thousand Oaks, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, 91320, USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006305632","display_name":"David H. Salinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Salinger","raw_affiliation_strings":["Amgen Inc, 1201 Amgen Court West, Seattle, WA, 98119, USA","Amgen Inc., Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, 1201 Amgen Court West, Seattle, WA, 98119, USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Amgen Inc., Seattle, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023166441","display_name":"Erin Stevens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin Stevens","raw_affiliation_strings":["Amgen Inc, 1201 Amgen Court West, Seattle, WA, 98119, USA","Amgen Inc., Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, 1201 Amgen Court West, Seattle, WA, 98119, USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Amgen Inc., Seattle, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070208317","display_name":"Chris B. Russell","orcid":"https://orcid.org/0000-0002-0240-1815","observed_orcids":["https://orcid.org/0000-0002-0240-1815"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris B Russell","raw_affiliation_strings":["Amgen Inc, 1201 Amgen Court West, Seattle, WA, 98119, USA","Amgen Inc., Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, 1201 Amgen Court West, Seattle, WA, 98119, USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Amgen Inc., Seattle, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016296602","display_name":"James B. Chung","orcid":"https://orcid.org/0000-0002-9775-0208","observed_orcids":["https://orcid.org/0000-0002-9775-0208"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James B Chung","raw_affiliation_strings":["Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, 91320, USA","Amgen Incorporated, Thousand Oaks, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, 91320, USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Amgen Incorporated, Thousand Oaks, USA","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":{"value":3690,"currency":"USD","value_usd":3690},"apc_paid":{"value":3690,"currency":"USD","value_usd":3690},"fwci":14.7645,"has_fulltext":true,"cited_by_count":108,"citation_normalized_percentile":{"value":0.99447935,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"15","issue":"5","first_page":"R164","last_page":"R164"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brodalumab","display_name":"brodalumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.968999981880188},{"id":"https://openalex.org/keywords/il-17-receptor-signaling","display_name":"IL-17 receptor signaling","score":0.6539999842643738},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8190000057220459},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.5379999876022339},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7429999709129333},{"id":"https://openalex.org/keywords/receptor-occupancy","display_name":"receptor occupancy","score":0.6629999876022339},{"id":"https://openalex.org/keywords/acr20-response","display_name":"ACR20 response","score":0.6740000247955322},{"id":"https://openalex.org/keywords/early-clinical-response","display_name":"early clinical response","score":0.6909999847412109},{"id":"https://openalex.org/keywords/multiple-ascending-dose","display_name":"multiple ascending dose","score":0.5889999866485596},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.6759999990463257},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.9890000224113464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8980376124382019},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6799597144126892},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6092778444290161},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.5543307662010193},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5331549048423767},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5229752063751221},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5014753341674805},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3900090456008911},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08868834376335144},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003371","descriptor_name":"Cough","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015746","descriptor_name":"Abdominal Pain","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053722","descriptor_name":"Receptors, Interleukin-17","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053722","descriptor_name":"Receptors, Interleukin-17","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/ar4347","doi":"https://doi.org/10.1186/ar4347","is_oa":true,"landing_page_url":"https://doi.org/10.1186/ar4347","pdf_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/ar4347","source":{"id":"https://openalex.org/S149170128","display_name":"Arthritis Research & Therapy","issn_l":"1478-6354","issn":["1478-6354","1478-6362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Research & Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2961458","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3979125","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3979125","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3979125","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Res Ther","raw_type":"Text"},{"id":"pmid:24286136","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24286136","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis research & therapy","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1186/ar4347","doi":"https://doi.org/10.1186/ar4347","is_oa":true,"landing_page_url":"https://doi.org/10.1186/ar4347","pdf_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/ar4347","source":{"id":"https://openalex.org/S149170128","display_name":"Arthritis Research & Therapy","issn_l":"1478-6354","issn":["1478-6354","1478-6362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Research & Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1606430500","display_name":"Pain Mechanisms and Outcomes in Osteoarthritis","funder_award_id":"K23AR060241","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2107583569.pdf","grobid_xml":"https://content.openalex.org/works/W2107583569.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1513992440","https://openalex.org/W1553271826","https://openalex.org/W1761300068","https://openalex.org/W1979036381","https://openalex.org/W1995088377","https://openalex.org/W2015494267","https://openalex.org/W2022917731","https://openalex.org/W2073441708","https://openalex.org/W2076456688","https://openalex.org/W2081734937","https://openalex.org/W2088569180","https://openalex.org/W2110555227","https://openalex.org/W2110826367","https://openalex.org/W2112128505","https://openalex.org/W2124853228","https://openalex.org/W2127834887","https://openalex.org/W2132784721","https://openalex.org/W2159788225","https://openalex.org/W2160258620","https://openalex.org/W2161415751","https://openalex.org/W2316600257"],"related_works":["https://openalex.org/W2161415751","https://openalex.org/W4238280041","https://openalex.org/W1924808736","https://openalex.org/W7096596802","https://openalex.org/W3175087306","https://openalex.org/W2053127888","https://openalex.org/W2319342693","https://openalex.org/W2334337629","https://openalex.org/W2340199069","https://openalex.org/W2316600257"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1,136],"aim":[2],"of":[3,15,103,133,150,156,177,195,206,212,224,237,246,259],"this":[4],"study":[5,44,137],"was":[6,138,248,256],"to":[7,49,64,124,131,141,263],"evaluate":[8],"the":[9],"safety,":[10],"pharmacokinetics,":[11],"and":[12,55,107,113,153,181,209,221,229,234],"clinical":[13,117,261],"response":[14,262],"brodalumab":[16,66,157,207,219,232,247,264],"(AMG":[17],"827),":[18],"a":[19,260],"human,":[20],"anti-IL-17":[21],"receptor":[22,179,182],"A":[23],"(IL-17RA)":[24],"monoclonal":[25],"antibody":[26],"in":[27,115,164,175,250,265],"subjects":[28,46,121,152,208,214,220,226,233,239,251,266],"with":[29,47,192,252,267],"moderate-to-severe":[30],"rheumatoid":[31],"arthritis":[32],"(RA).":[33],"METHODS:":[34],"This":[35],"phase":[36],"Ib,":[37],"randomized,":[38],"placebo-controlled,":[39],"double-blind":[40],"multiple":[41],"ascending":[42],"dose":[43,244],"enrolled":[45],"moderate":[48],"severe":[50],"RA":[51,116,134,196],"(\u2265":[52],"6/66":[53],"swollen":[54],"\u2265":[56],"8/68":[57],"tender":[58],"joints).":[59],"Subjects":[60],"were":[61,122,145,162,168,190],"randomized":[62,123],"3:1":[63],"receive":[65],"(50":[67],"mg,":[68,70],"140":[69],"or":[71,83,86,98],"210":[72],"mg":[73,85,88],"subcutaneously":[74],"every":[75,90],"two":[76,94,165],"weeks":[77,92],"for":[78,93],"6":[79],"doses":[80,95],"per":[81,96],"group;":[82],"420":[84],"700":[87],"intravenously":[89],"4":[91],"group)":[97],"placebo.":[99],"Endpoints":[100],"included":[101,111],"incidence":[102],"adverse":[104],"events":[105],"(AEs)":[106],"pharmacokinetics.":[108],"Exploratory":[109],"endpoints":[110],"pharmacodynamics,":[112],"improvements":[114],"metrics.":[118],"RESULTS:":[119],"Forty":[120],"investigational":[125],"product;":[126],"one":[127],"subject":[128],"discontinued":[129],"due":[130],"worsening":[132],"(placebo).":[135],"not":[139],"designed":[140],"assess":[142],"efficacy.":[143],"AEs":[144,161],"reported":[146,163],"by":[147],"70%":[148],"(7/10)":[149],"placebo":[151,213,225,238],"77%":[154],"(22/30)":[155],"subjects.":[158],"Three":[159],"serious":[160],"subjects;":[166],"there":[167],"no":[169,257],"opportunistic":[170],"infections.":[171],"Brodalumab":[172],"treatment":[173,188],"resulted":[174],"inhibition":[176],"IL-17":[178],"signaling":[180],"occupancy":[183],"on":[184],"circulating":[185],"leukocytes.":[186],"No":[187],"effects":[189],"observed":[191],"individual":[193],"measures":[194],"disease":[197],"activity.":[198],"On":[199],"day":[200],"85":[201],"(week":[202],"13)":[203],"37%":[204],"(11/30)":[205],"22%":[210],"(2/9)":[211],"achieved":[215,227,240],"ACR20;":[216],"7%":[217],"(2/30)":[218],"11%":[222],"(1/9)":[223],"ACR50;":[228],"0%":[230,235],"(0/30)":[231],"(0/9)":[236],"ACR70.":[241],"CONCLUSIONS:":[242],"Multiple":[243],"administration":[245],"tolerated":[249],"active":[253],"RA.":[254,268],"There":[255],"evidence":[258],"TRIAL":[269],"REGISTRATION:":[270],"ClinicalTrials.gov,":[271],"NCT00771030.":[272]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":30},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}